#Latest news with #GerBrophyCNBC3 days agoBusinessCNBCCNBC Disruptor 50: ElevateBio CEO Ger Brophy on AI and CRISPR for rare disease treatmentsElevateBio CEO Ger Brophy joins 'Worldwide Exchange' as ElevateBio ranks #43 on the Disruptor 50 list.
CNBC3 days agoBusinessCNBCCNBC Disruptor 50: ElevateBio CEO Ger Brophy on AI and CRISPR for rare disease treatmentsElevateBio CEO Ger Brophy joins 'Worldwide Exchange' as ElevateBio ranks #43 on the Disruptor 50 list.
3 days ago
